Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Neuromodulation and Cognitive Training in Opioid Use Disorder

NCT: NCT03773523 · ACTIVE_NOT_RECRUITING

NCT IDNCT03773523
StatusACTIVE_NOT_RECRUITING
Start Date2019-08-01
Completion2027-05-15
SponsorUniversity of Minnesota (OTHER)
First posted
Last updated

Brief Summary

The relapsing nature of opioid use disorder is a major obstacle to successful treatment. About 90% of those entering treatment will relapse within one year. To improve treatment outcome, new interventions targeting the underlying brain biomarkers of relapse vulnerability hold significant promise in reducing this critical public health problem. Transcranial direct current stimulation (tDCS) is a non-invasive brain stimulation technique that can modulate brain connectivity.

Frequently Asked Questions

What is Neuromodulation and Cognitive Training in Opioid Use Disorder?

Neuromodulation and Cognitive Training in Opioid Use Disorder is a clinical trial registered under NCT03773523. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT03773523?

The current status of NCT03773523 (Neuromodulation and Cognitive Training in Opioid Use Disorder) is: ACTIVE_NOT_RECRUITING.

When did Neuromodulation and Cognitive Training in Opioid Use Disorder start?

Neuromodulation and Cognitive Training in Opioid Use Disorder started on 2019-08-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.